• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Recent Industry Personnel News

Recent Industry Personnel News

August 15, 2007
CenterWatch Staff
  • Wilmington, N.C.-based contract research organization (CRO) PPD promoted Susan Atkinson to senior vice president for global statistics and data management. Her duties will include overseeing electronic data capture operations and informatics. Atkinson began at PPD in 1991 as a senior biostatistician and most recently led PPD’s U.S. biostatistics, programming and data management operations.

  • Whitehouse, N.J.-based pharmaceutical company Merck named David E. Kelley, M.D., as vice president of the company’s diabetes and obesity research franchise. His will lead the group's investigators in biomarker, experimental medicine and imaging activities to help optimize drugs through phase II clinical trials. Kelley spent 20 years at the University of Pittsburg studying insulin resistance and diabetes. He was most recently the director of the Obesity & Nutrition Research Center.
  • London-based CRO Chiltern International’s Patricia Lovell-Hoare, the company’s executive vice president of regulatory affairs, as been invited to become a Fellow at the Royal Society of Medicine. 
  • Gaithersburg, Mary.-based preclinical CRO Bridge Pharmaceuticals has restructured its executive management team after it hired Thomas Oakley as chief executive officer. Prior to joining Bridge, Oakley was founder and president of the consulting firm DTO Associates. Previously, he worked at the CRO Covance for nine years as global vice president of finance for its early stage group. Bridge also appointed Patrick Jeanmonod as chief financial officer and promoted Ronald Marler to chief scientific officer.
  • London-based CRO Premier Research appointed Chris Nowell vice president of clinical trial management for the company’s international division. Most recently, Nowell was director of project management at Quintiles. He also has held clinical posts at Bayer.
  • Cincinnati-based CRO Kendle appointed Thomas Smith, M.D., to vice president of medical affairs. He will lead the company’s global medical affairs organization in charge of the group’s medical directors who advise clients on protocol design, endpoint selection and inclusion/exclusion criteria. Smith was most recently a global medical director in that group. Prior to joining Kendle, he held various positions at Akros Pharma, Genzyme and Abbott.



Be sure to send your organization's latest personnel news via email to the editors at Clinical Trials Today!

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing